Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplants are generally satisfying and successful, but transplanted hair can thin over time.

Systemic minoxidil might help maintain hair regrowth in alopecia areata.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Most women with hyperandrogenism first show acne, and skin conditions like hirsutism and acanthosis nigricans are good indicators of the condition.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Zinc levels don't significantly affect hair loss, so testing for zinc isn't necessary.

COVID-19 increased hair loss cases, but vaccination did not.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Over half of the children had abnormal hair under a microscope, with many having genetic hair conditions.

Follicular unit extraction is an effective hair transplant method for advanced baldness with high patient satisfaction, but some experienced decreased density over time.

People with autism are more likely to develop alopecia areata than those without autism.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Low-dose oral minoxidil effectively treats hair loss with good tolerance.

Routine monitoring isn't needed for healthy patients on low-dose oral minoxidil, but is advised for those with kidney issues.

Hair and nails contain stable RNA, useful for personalized medicine and screening.

Spironolactone does not increase the risk of breast cancer recurrence.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.